Evidence map›Paper›PMID 37880891›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023

TB therapeutic drug monitoring - analysis of opportunities in Romania and Ukraine.

I Margineanu, T Butnaru, F Gafar, D Baiceanu, R Dragomir, I Semianiv, F Mihaltan, I Munteanu, B Mahler, L Todoriko and 4 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

I MargineanuDepartment of Clinical Pharmacy and Pharmacology, University Medical Centrum Groningen, University of Groningen, Groningen, The Netherlands.
T ButnaruProf Dr Marius Nasta Institute for Pneumology, Bucharest, Romania.
F GafarUnit of Pharmacotherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.
D BaiceanuProf Dr Marius Nasta Institute for Pneumology, Bucharest, Romania.
R DragomirProf Dr Marius Nasta Institute for Pneumology, Bucharest, Romania.
I SemianivChernivtsi TB Expertise Centre, Bukovinian State Medical University, Chernivtsi, Ukraine.
F MihaltanProf Dr Marius Nasta Institute for Pneumology, Bucharest, Romania.
I MunteanuProf Dr Marius Nasta Institute for Pneumology, Bucharest, Romania.
B MahlerProf Dr Marius Nasta Institute for Pneumology, Bucharest, Romania.
L TodorikoChernivtsi TB Expertise Centre, Bukovinian State Medical University, Chernivtsi, Ukraine.
S MargineanuDepartment of Computer and Data Sciences, Ion Ionescu de la Brad Iasi University of Life Sciences, Iasi, Romania.
O AkkermanDepartment of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, Tuberculosis Center Beatrixoord, University Medical Center Groningen, University of Groningen, Haren.
Y StienstraDepartment of Internal Medicine/Infectious Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
J-W C AlffenaarDepartment of Clinical Pharmacy and Pharmacology, University Medical Centrum Groningen, University of Groningen, Groningen, The Netherlands, Faculty of Medicine and Health, School of Pharmacy, and, Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW, Westmead Hospital, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

TuberculosisAdultDrug MonitoringHumansRetrospective StudiesRomaniaUkraine

Identifiers

PMID37880891
PMCPMC10599412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.